U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H28O
Molecular Weight 284.4357
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LYNESTRENOL

SMILES

[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]3([H])[C@@]4([H])CCCC=C4CC[C@@]23[H]

InChI

InChIKey=YNVGQYHLRCDXFQ-XGXHKTLJSA-N
InChI=1S/C20H28O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h1,6,15-18,21H,4-5,7-13H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1

HIDE SMILES / InChI

Molecular Formula C20H28O
Molecular Weight 284.4357
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Lynestrenol is a progestogen structurally related to norethisterone; it is used singularly, or as the progestogenic component of oral contraceptives. It is also used in treatments for menstrual disorders. Lynestrenol is typically used as an oral contraceptive, but also for the treatment of menstrual disorders like: Oligo-menorrhea and hypo-menorrhea; Polymenorrhoea; Fibrocystic mastopathy; Endometriosis; Endometrial carcinoma and/or metastases etc. As a synthetic oral progestogen, Lynestrenol has similar effects as that of the natural progesterone hormone. It has a strong progestational effect on the uterine endometrium by transforming the proliferative endometrium into a secretory one. It also inhibits the secretion of gonadotropin, suppresses maturation of follicles in the ovaries and ovulation, and reduces menstrual bleeding. Lynestrenol has minimal estrogenic, androgenic and anabolic effects.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Variegate porphyria with coexistent decrease in porphobilinogen deaminase activity.
2001 Oct-Nov
FSH and ovarian response: spontaneous recovery of pituitary-ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives.
2002 Apr
Classification and pharmacology of progestins.
2003 Dec 10
[Multiple endometrial polyps in patient undergoing long-term gestagen therapy].
2005 Sep-Oct
Breast cancer risk associated with different HRT formulations: a register-based case-control study.
2006 Sep 12
Benefits and risks of hormonal contraception for women.
2007 Aug 10
Oral progestagens before menopause and breast cancer risk.
2007 Mar 12
Laparoscopic hysterectomy of large uteri with uterine artery coagulation at its origin.
2008 Jan-Mar
Protrhombotic effects of contraceptives.
2010
Gene expression signatures of breast tissue before and after cross-sex hormone therapy in female-to-male transsexuals.
2010 Dec
Patents

Patents

Sample Use Guides

lynestrenol (LYN) in a dose of 15 mg/d
Route of Administration: Oral
In Vitro Use Guide
Lynestrenol markedly enhanced the lymphocyte response to phytohemagglutinin, the mixed lymphocyte culture, the active T-rosette test, the autologous red cell rosettes, and the number of nonadherent cells in the leukocyte adherence inhibition test. Lynestrenol also increased monocyte phagocytosis.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:11:03 GMT 2023
Edited
by admin
on Fri Dec 15 15:11:03 GMT 2023
Record UNII
N2Z8ALG4U5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LYNESTRENOL
EP   INN   JAN   MART.   MI   USAN   USP-RS   WHO-DD  
USAN   INN  
Official Name English
LYNOESTRENOL
Common Name English
LYNESTRENOL [MART.]
Common Name English
LYNESTRENOL [MI]
Common Name English
19-Nor-17α-pregn-4-en-20-yn-17-ol
Common Name English
LYNESTRENOL [USAN]
Common Name English
lynestrenol [INN]
Common Name English
LYNESTRENOL [USP-RS]
Common Name English
19 NORPREGN-4-EN-20-YN-17-OL, (17.ALPHA.)-
Common Name English
LYNESTRENOL [JAN]
Common Name English
LYNESTRENOL [EP MONOGRAPH]
Common Name English
Lynestrenol [WHO-DD]
Common Name English
NSC-37725
Code English
Classification Tree Code System Code
WHO-VATC QG03AB02
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
WHO-VATC QG03FB02
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
NCI_THESAURUS C776
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
WHO-VATC QG03DC03
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
WHO-VATC QG03FA07
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
WHO-ATC G03AC02
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
WHO-VATC QG03AC02
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
WHO-ATC G03AA03
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
WHO-ATC G03FB02
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
WHO-VATC QG03AA03
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
WHO-ATC G03AB02
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
WHO-ATC G03DC03
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
WHO-ATC G03FA07
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
Code System Code Type Description
EVMPD
SUB08626MIG
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
SMS_ID
100000091360
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
RS_ITEM_NUM
1370906
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
ChEMBL
CHEMBL2107431
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
FDA UNII
N2Z8ALG4U5
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
DRUG BANK
DB12474
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
MERCK INDEX
m6960
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY Merck Index
RXCUI
6529
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY RxNorm
CAS
52-76-6
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
HSDB
7899
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
NSC
37725
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
INN
1222
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
ECHA (EC/EINECS)
200-151-4
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
PUBCHEM
5857
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
NCI_THESAURUS
C90969
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
EPA CompTox
DTXSID4021478
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
DRUG CENTRAL
1620
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
WIKIPEDIA
Lynestrenol
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
MESH
D008234
Created by admin on Fri Dec 15 15:11:03 GMT 2023 , Edited by admin on Fri Dec 15 15:11:03 GMT 2023
PRIMARY
Related Record Type Details
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (GC)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (GC)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (GC)
EP
Related Record Type Details
ACTIVE MOIETY